Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Aligos Therapeutics logo

Aligos Therapeutics

Recent Finacing

Equity

Recent Raise

$92M

Aligos Therapeutics is a preclinical-stage biotechnology company based in South San Francisco developing targeted therapies for liver diseases and viral infections, including chronic hepatitis B, NASH, and hepatocellular carcinoma.

Founded 2018
California, United States
51-100
Publicly Traded
aligos.com

Highlights

Focus Areas

Biotechnology

Recent Investors

Vivo Capital logo
Janus Henderson Investors logo
Versant Ventures logo
Wellington Management logo
Logos Capital logo
Roche logo
Boxer Capital logo
Cormorant Asset Management logo
Pivotal bioVenture Partners logo
Novo Holdings logo

Financials

$217M

Total Raised

2

Funding rounds

10

Investors


Team

Upgrade to view the team

See the team members at Aligos Therapeutics.